183 related articles for article (PubMed ID: 37658049)
1. IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m
Chen LJ; Liu HY; Xiao ZY; Qiu T; Zhang D; Zhang LJ; Han FY; Chen GJ; Xu XM; Zhu JH; Ding YQ; Wang SY; Ye YP; Jiao HL
Cell Death Dis; 2023 Sep; 14(9):581. PubMed ID: 37658049
[TBL] [Abstract][Full Text] [Related]
2.
Zhao A; Wang Y; Wang Z; Shao Q; Gong QI; Zhu H; Shen S; Liu HU; Chen X
Oncol Res; 2024; 32(5):983-998. PubMed ID: 38686044
[TBL] [Abstract][Full Text] [Related]
3. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
[TBL] [Abstract][Full Text] [Related]
4. The RNA m
Ge L; Rui Y; Wang C; Wu Y; Wang H; Wang J
Cell Death Dis; 2024 Mar; 15(3):192. PubMed ID: 38448411
[TBL] [Abstract][Full Text] [Related]
5. PHLDB2 Mediates Cetuximab Resistance via Interacting With EGFR in Latent Metastasis of Colorectal Cancer.
Luo M; Huang Z; Yang X; Chen Y; Jiang J; Zhang L; Zhou L; Qin S; Jin P; Fu S; Peng L; Li B; Fang Y; Pu W; Gong Y; Liu Y; Ren Z; Liu QL; Wang C; Xiao F; He D; Zhang H; Li C; Xu H; Dai L; Peng Y; Zhou ZG; Huang C; Chen HN
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1223-1242. PubMed ID: 34952201
[TBL] [Abstract][Full Text] [Related]
6. FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m
Hu Y; Gao Q; Ma S; Yu P; Ding S; Yao X; Zhang Z; Lu S; Lu M; Zhang J; Wang Y; Qian X; Zhong J
Cell Death Dis; 2022 Nov; 13(11):941. PubMed ID: 36347844
[TBL] [Abstract][Full Text] [Related]
7. Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo.
Xu W; Sheng Y; Guo Y; Huang Z; Huang Y; Wen D; Liu CY; Cui L; Yang Y; Du P
J Cell Physiol; 2019 Aug; 234(10):18466-18479. PubMed ID: 30895618
[TBL] [Abstract][Full Text] [Related]
8. Binding of RNA m6A by IGF2BP3 triggers chemoresistance of HCT8 cells via upregulation of ABCB1.
Yang Z; Zhao F; Gu X; Feng L; Xu M; Li T; Liu X; Zhang X
Am J Cancer Res; 2021; 11(4):1428-1445. PubMed ID: 33948366
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanism of RNA binding motif protein 15-mediated N
Chen J
Environ Toxicol; 2023 Nov; 38(11):2545-2559. PubMed ID: 37471637
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP3-EGFR-AKT axis promotes breast cancer MDA-MB-231 cell growth.
Jing X; Han C; Li Q; Li F; Zhang J; Jiang Q; Zhao F; Guo C; Chen J; Jiang T; Wang X; Chen Y; Huang C
Biochim Biophys Acta Mol Cell Res; 2023 Dec; 1870(8):119542. PubMed ID: 37474008
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
13. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Lin Z; Li J; Zhang J; Feng W; Lu J; Ma X; Ding W; Ouyang S; Lu J; Yue P; Wan G; Liu P; Zhang X
Cancer Res; 2023 Jul; 83(13):2187-2207. PubMed ID: 37061993
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of oncogenic transcripts by the IGF2BP3/ELAVL1 complex promotes tumorigenicity in colorectal cancer.
Li K; Huang F; Li Y; Li D; Lin H; Ni R; Zhang Q; Zhao M; Huang S; Zou L; Huang C
Am J Cancer Res; 2020; 10(8):2480-2494. PubMed ID: 32905413
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
Zhang X; Shi L; Sun HD; Wang ZW; Xu F; Wei JF; Ding Q
Clin Transl Med; 2023 Sep; 13(9):e1427. PubMed ID: 37743642
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
Xing Y; Jing H; Zhang Y; Suo J; Qian M
Int J Biochem Cell Biol; 2020 Jan; 118():105643. PubMed ID: 31704502
[TBL] [Abstract][Full Text] [Related]
17. Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1/S phase arrest in colorectal cancer cells.
Gui Z; Li J; Li J; Li X; Chen L; Ma Z; Tang X; Gong X; Chai X; Lu F; Li M; Ma H; Li X; Ye X
Chem Biol Interact; 2023 Apr; 374():110408. PubMed ID: 36822301
[TBL] [Abstract][Full Text] [Related]
18. Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.
Rodrigues JG; Duarte HO; Gomes C; Balmaña M; Martins ÁM; Hensbergen PJ; de Ru AH; Lima J; Albergaria A; van Veelen PA; Wuhrer M; Gomes J; Reis CA
Cell Oncol (Dordr); 2021 Aug; 44(4):835-850. PubMed ID: 33847896
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Xanthakis I; Sgouros J; Televantou D; Kafiri G; Tsamandas AC; Razis E; Galani E; Bafaloukos D; Efstratiou I; Bompolaki I; Pectasides D; Pavlidis N; Tejpar S; Fountzilas G
BMC Cancer; 2013 Feb; 13():49. PubMed ID: 23374602
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor-targeted therapy in colorectal cancer.
Xu W; Jing H; Zhang F
Front Biosci (Landmark Ed); 2016 Jan; 21(2):410-8. PubMed ID: 26709782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
